CONMED Total Liabilities 2010-2022 | CNMD

CONMED total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
CONMED Annual Total Liabilities
(Millions of US $)
2021 $981
2020 $1,043
2019 $1,065
2018 $707
2017 $727
2016 $748
2015 $517
2014 $517
2013 $484
2012 $472
2011 $363
2010 $399
2009 $382
CONMED Quarterly Total Liabilities
(Millions of US $)
2022-06-30 $1,399
2022-03-31 $996
2021-12-31 $981
2021-09-30 $998
2021-06-30 $1,017
2021-03-31 $1,021
2020-12-31 $1,043
2020-09-30 $1,060
2020-06-30 $1,049
2020-03-31 $1,049
2019-12-31 $1,065
2019-09-30 $1,057
2019-06-30 $1,062
2019-03-31 $1,068
2018-12-31 $707
2018-09-30 $710
2018-06-30 $716
2018-03-31 $707
2017-12-31 $727
2017-09-30 $772
2017-06-30 $753
2017-03-31 $753
2016-12-31 $748
2016-09-30 $747
2016-06-30 $759
2016-03-31 $760
2015-12-31 $517
2015-09-30 $517
2015-06-30 $511
2015-03-31 $514
2014-12-31 $517
2014-09-30 $517
2014-06-30 $495
2014-03-31 $488
2013-12-31 $484
2013-09-30 $492
2013-06-30 $498
2013-03-31 $485
2012-12-31 $472
2012-09-30 $486
2012-06-30 $468
2012-03-31 $490
2011-12-31 $363
2011-09-30 $389
2011-06-30 $383
2011-03-31 $391
2010-12-31 $399
2010-09-30 $423
2010-06-30 $408
2010-03-31 $408
2009-12-31 $382
2009-09-30 $381
2009-06-30 $368
2009-03-31 $373
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.435B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.063B 19.19
McKesson (MCK) United States $49.282B 14.31
AmerisourceBergen (ABC) United States $28.260B 12.61
Laboratory Of America Holdings (LH) United States $19.507B 8.53
West Pharmaceutical Services (WST) United States $18.722B 28.50
Cardinal Health (CAH) United States $17.923B 13.00
Cooper (COO) United States $13.274B 20.77
Invacare (IVC) United States $0.031B 0.00